(Q38078058)

English

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

scientific article published on March 2013

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

main subject

multiple drug resistance

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

author name string

Afsaneh Lavasanifar

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

publication date

1 March 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

published in

Current Cancer Drug Targets

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

page(s)

326-346

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23369096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23369096%20AND%20SRC:MED&resulttype=core&format=json

(Q38078058)

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)